These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 14519765)

  • 1. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
    Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
    J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.
    Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M
    Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
    Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
    J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
    Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
    Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
    Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
    Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.
    Funami K; Matsumoto M; Enokizono Y; Ishii N; Tatematsu M; Oshiumi H; Inagaki F; Seya T
    J Immunol; 2015 Nov; 195(9):4456-65. PubMed ID: 26408662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.
    Funami K; Sasai M; Oshiumi H; Seya T; Matsumoto M
    J Biol Chem; 2008 Jun; 283(26):18283-91. PubMed ID: 18450748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
    Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T
    J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif.
    Kaiser WJ; Offermann MK
    J Immunol; 2005 Apr; 174(8):4942-52. PubMed ID: 15814722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
    Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
    J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.